Clinical trial

HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer

NCT00401427

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record trastuzumab Normalized identity: trastuzumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record vinorelbine Normalized identity: vinorelbineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-11-01

PhasePHASE2

Conditions

Metastatic Breast Cancerunresolved

Interventions

trastuzumabDRUG · verified · RxNorm: trastuzumab

vinorelbineDRUG · verified · RxNorm: vinorelbine

Sponsors & collaborators

National Cancer Institute, Napleslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00401427 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.